Thyroid tablets recalled nationwide over potential ‘superpotency’: FDA

Read full story on The Hill
Share
Thyroid tablets recalled nationwide over potential ‘superpotency’: FDA
AI disclosure

Summary

Patients taking the affected lot are advised not to discontinue use without first consulting their health care provider.

Original reporting

Open original source
Read full article on The Hill

Get the AFBytes Brief

Major stories, AI-assisted analysis, and what to watch next. Free, monthly, unsubscribe anytime.